Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment.
作者信息
Gisondi Paolo, Zaza Gianluigi, Del Giglio Micol, Rossi Mattia, Iacono Valentina, Girolomoni Giampiero
机构信息
Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
Section of Nephrology, Department of Medicine, University of Verona, Verona, Italy.
出版信息
J Am Acad Dermatol. 2020 Jul;83(1):285-287. doi: 10.1016/j.jaad.2020.04.085. Epub 2020 Apr 21.
Abstract
摘要
相似文献
1
Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment.
J Am Acad Dermatol. 2020 Jul;83(1):285-287. doi: 10.1016/j.jaad.2020.04.085. Epub 2020 Apr 21.
2
The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.
Br J Dermatol. 2020 Aug;183(2):373-374. doi: 10.1111/bjd.19158. Epub 2020 May 28.
3
A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.
Kidney Int. 2020 Jun;97(6):1083-1088. doi: 10.1016/j.kint.2020.04.002. Epub 2020 Apr 9.
4
Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study.
J Am Acad Dermatol. 2020 Oct;83(4):1212-1214. doi: 10.1016/j.jaad.2020.07.021. Epub 2020 Jul 15.
5
COVID-19 in a Kidney Transplant Patient.
Eur Urol. 2020 Jun;77(6):769-770. doi: 10.1016/j.eururo.2020.03.036. Epub 2020 Apr 6.
6
Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy.
J Am Acad Dermatol. 2020 Oct;83(4):1215-1218. doi: 10.1016/j.jaad.2020.06.999. Epub 2020 Jul 2.
7
Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China.
Eur Urol. 2020 Jun;77(6):748-754. doi: 10.1016/j.eururo.2020.03.039. Epub 2020 Apr 18.
8
COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy.
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):532-533. doi: 10.1016/S2468-1253(20)30116-3. Epub 2020 Apr 9.
9
COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, Italy.
J Am Acad Dermatol. 2020 Jul;83(1):292-294. doi: 10.1016/j.jaad.2020.04.165. Epub 2020 May 6.
10
The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.
J Am Acad Dermatol. 2020 Aug;83(2):677-679. doi: 10.1016/j.jaad.2020.05.035. Epub 2020 May 19.
引用本文的文献
1
COVID-19 Among Patients with Psoriasis: A Single-Center Retrospective Cross-Sectional Study.
Infect Dis Clin Microbiol. 2023 Jun 23;5(2):127-135. doi: 10.36519/idcm.2023.192. eCollection 2023 Jun.
2
Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine.
Front Immunol. 2024 Jan 30;15:1354729. doi: 10.3389/fimmu.2024.1354729. eCollection 2024.
3
The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness.
Curr Dermatol Rep. 2023;12(2):45-55. doi: 10.1007/s13671-023-00385-w. Epub 2023 Apr 3.
4
Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?
Int J Mol Sci. 2022 Oct 14;23(20):12260. doi: 10.3390/ijms232012260.
5
COVID-19 Pandemic Impact on Severe Alopecia Areata Patients.
Skin Appendage Disord. 2022 May;8(3):195-199. doi: 10.1159/000520422. Epub 2021 Dec 20.
6
The role of gender, race, and ethnicity in psoriasis patients with COVID-19 infection: A cross-sectional study.
Int J Womens Dermatol. 2022 Mar 21;8(1):e012. doi: 10.1097/JW9.0000000000000012. eCollection 2022 Mar.
7
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease.
Biomedicines. 2022 Jan 21;10(2):228. doi: 10.3390/biomedicines10020228.
8
Management of Psoriasis During the Coronavirus Disease 2019 Pandemic.
J Clin Aesthet Dermatol. 2021 Sep;14(9):41-44.
9
Updates on Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by IADVL SIG Leprosy.
Indian Dermatol Online J. 2021 Nov 25;12(Suppl 1):S24-S30. doi: 10.4103/idoj.idoj_513_21. eCollection 2021 Nov.
10
COVID-19 and Dermatology in Iran.
Clin Dermatol. 2021 Jul-Aug;39(4):703-706. doi: 10.1016/j.clindermatol.2021.05.022. Epub 2021 May 18.
本文引用的文献
1
Should biologics for psoriasis be interrupted in the era of COVID-19?
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
2
Should patients stop their biologic treatment during the COVID-19 pandemic.
J Dermatolog Treat. 2020 Jun;31(4):317-318. doi: 10.1080/09546634.2020.1742438. Epub 2020 Mar 19.
Zotero 插件